BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 15500127)

  • 1. [Focal segmental glomerulosclerosis].
    Yuzawa Y; Matsuo S
    Nihon Rinsho; 2004 Oct; 62(10):1837-41. PubMed ID: 15500127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoexpression of podocyte-associated proteins in acquired human glomerulopathies with nephrotic syndrome.
    Wagrowska-Danilewicz M; Stasikowska O; Danilewicz M
    Pol J Pathol; 2006; 57(1):17-21. PubMed ID: 16739878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Animal models of FSGS: lessons for pathogenesis and treatment.
    Fogo AB
    Semin Nephrol; 2003 Mar; 23(2):161-71. PubMed ID: 12704576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRPC6 and FSGS: the latest TRP channelopathy.
    Mukerji N; Damodaran TV; Winn MP
    Biochim Biophys Acta; 2007 Aug; 1772(8):859-68. PubMed ID: 17459670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The genetic basis of FSGS and steroid-resistant nephrosis.
    Pollak MR
    Semin Nephrol; 2003 Mar; 23(2):141-6. PubMed ID: 12704574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The genetic basis of familial focal segmental glomerulosclerosis and related nephrotic syndrome].
    Tsukaguchi H; Kitamura A
    Nihon Jinzo Gakkai Shi; 2007; 49(2):88-97. PubMed ID: 17375615
    [No Abstract]   [Full Text] [Related]  

  • 7. Bigenic heterozygosity and the development of steroid-resistant focal segmental glomerulosclerosis.
    Löwik M; Levtchenko E; Westra D; Groenen P; Steenbergen E; Weening J; Lilien M; Monnens L; van den Heuvel L
    Nephrol Dial Transplant; 2008 Oct; 23(10):3146-51. PubMed ID: 18443213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Structure and function of the glomerular filtration barrier].
    Musiał K; Zwolińska D
    Pol Merkur Lekarski; 2005 Mar; 18(105):317-20. PubMed ID: 15997642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Structure and function of podocyte].
    Kawachi H; Miyauchi N; Han GD
    Nihon Rinsho; 2006 Feb; 64 Suppl 2():70-3. PubMed ID: 16523862
    [No Abstract]   [Full Text] [Related]  

  • 10. [A genetic viewpoint of focal glomerular sclerosis: fom genes to glomerular pathophysiology [corrected]].
    Aucella F; Bisceglia L; Stallone C
    G Ital Nefrol; 2003; 20(4):356-67. PubMed ID: 14523896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressive treatment of idiopathic focal segmental glomerulosclerosis: a five-year follow-up study.
    Goumenos DS; Tsagalis G; El Nahas AM; Shortland JR; Davlouros P; Vlachojannis JG; Brown CB
    Nephron Clin Pract; 2006; 104(2):c75-82. PubMed ID: 16785738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of synaptopodin and GLEPP1 as markers of steroid responsiveness in primary focal segmental glomerulosclerosis.
    Hirakawa M; Tsuruya K; Yotsueda H; Tokumoto M; Ikeda H; Katafuchi R; Fujimi S; Hirakata H; Iida M
    Life Sci; 2006 Jul; 79(8):757-63. PubMed ID: 16564554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of disease: focal segmental glomerulosclerosis.
    Meyrier A
    Nat Clin Pract Nephrol; 2005 Nov; 1(1):44-54. PubMed ID: 16932363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Focal segmental glomerulosclerosis (FSGS). Molecular defects and clinical relevance].
    Schiffer M; Haller H
    Dtsch Med Wochenschr; 2006 Jul; 131(27):1541-5. PubMed ID: 16817104
    [No Abstract]   [Full Text] [Related]  

  • 15. [Focal segmental glomerulosclerosis (FSGS)].
    Sato H
    Nihon Jinzo Gakkai Shi; 2010; 52(7):888-93. PubMed ID: 21077336
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular basis of steroid-resistant nephrotic syndrome.
    Antignac C
    Nefrologia; 2005; 25 Suppl 2():25-8. PubMed ID: 16050398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. R168H and V165X mutant podocin might induce different degrees of podocyte injury via different molecular mechanisms.
    Fan Q; Zhang H; Ding J; Liu S; Miao J; Xing Y; Yu Z; Guan N
    Genes Cells; 2009 Sep; 14(9):1079-90. PubMed ID: 19674119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD2-associated protein and glomerular disease.
    Wolf G; Stahl RA
    Lancet; 2003 Nov; 362(9397):1746-8. PubMed ID: 14643126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD2AP mutations are associated with sporadic nephrotic syndrome and focal segmental glomerulosclerosis (FSGS).
    Gigante M; Pontrelli P; Montemurno E; Roca L; Aucella F; Penza R; Caridi G; Ranieri E; Ghiggeri GM; Gesualdo L
    Nephrol Dial Transplant; 2009 Jun; 24(6):1858-64. PubMed ID: 19131354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular mechanism of proteinuria and new therapeutic approach against proteinuria].
    Yuzawa Y
    Nihon Rinsho; 2006 Feb; 64 Suppl 2():355-9. PubMed ID: 16523915
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.